Cardica To Present At 2014 Wedbush PacGrow Life Sciences Management Access Conference

  Cardica To Present At 2014 Wedbush PacGrow Life Sciences Management Access                                   Conference  PR Newswire  REDWOOD CITY, Calif., Aug. 4, 2014  REDWOOD CITY, Calif., Aug. 4, 2014 /PRNewswire/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that Bernard A. Hausen, M.D., Ph.D., the company's president and CEO, is scheduled to present a corporate overview and update at the 2014 Wedbush PacGrow Life Sciences Management Access Conference on Tuesday, August 12 at 12:45 p.m. Eastern Time.  To access the live and subsequently archived webcast of the presentation, go to the Investor Relations section of the company's website at http://www.cardica.com. Please connect to the website at least 15 minutes prior to the presentation to allow for any necessary software downloads.  About Cardica Cardicadesigns and manufactures proprietary stapling and anastomotic devices for laparoscopic and cardiac surgical procedures.Cardica's technology portfolio is intended to reduce operating time and facilitate minimally-invasive and robot-assisted surgeries. Cardica's MicroCutter XCHANGE^® 30, a cartridge-based articulating surgical stapling device with a five-millimeter shaft diameter, is manufactured and cleared for use in a variety of gastrointestinal procedures and appendectomies in the United States, and is marketed for a wide range of surgical procedures in Europe. Cardicais developing the Cardica^® MicroCutter XCHANGE^® 45, a cartridge-based microcutter device that is being designed with an eight-millimeter shaft to be used in a variety of procedures, including bariatric, colorectal, thoracic and general surgery. The Cardica MicroCutter XCHANGE 45 product requires 510(k) clearance and CE Mark before it may be sold in the United States and Europe, respectively, and is not yet commercially available in the U.S. or internationally. In addition, Cardica manufactures and markets its automated anastomosis systems, the C-Port^® Distal Anastomosis Systems and PAS-Port^® Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery, and has shipped over 50,000 units throughout the world.  SOURCE Cardica  Website: http://www.cardica.com Contact: Bob Newell, Vice President, Finance and Chief Financial Officer, (650) 331-7133, investors@cardica.com  
Press spacebar to pause and continue. Press esc to stop.